Applied DNA Sciences Analyst Ratings
Applied DNA Sciences Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/24/2023 | 175.86% | HC Wainwright & Co. | → $4 | Reiterates | Buy → Buy |
08/14/2023 | 175.86% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
07/14/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
05/12/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
05/08/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
03/30/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
03/23/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
02/10/2023 | 244.83% | HC Wainwright & Co. | → $5 | Reiterates | → Buy |
12/15/2022 | 244.83% | HC Wainwright & Co. | $8 → $5 | Maintains | Buy |
08/08/2022 | 451.72% | HC Wainwright & Co. | $4 → $8 | Maintains | Buy |
05/16/2022 | 175.86% | HC Wainwright & Co. | $6 → $4 | Maintains | Buy |
02/11/2022 | 313.79% | HC Wainwright & Co. | $8 → $6 | Maintains | Buy |
08/13/2021 | 658.62% | HC Wainwright & Co. | $13 → $11 | Maintains | Buy |
04/22/2021 | 796.55% | HC Wainwright & Co. | $14 → $13 | Maintains | Buy |
02/12/2021 | 1555.17% | Roth Capital | → $24 | Initiates Coverage On | → Buy |
01/14/2021 | 865.52% | HC Wainwright & Co. | $18 → $14 | Maintains | Buy |
01/11/2021 | 1141.38% | HC Wainwright & Co. | $12 → $18 | Maintains | Buy |
11/30/2020 | 1279.31% | HC Wainwright & Co. | $22 → $20 | Maintains | Buy |
07/20/2020 | 1417.24% | HC Wainwright & Co. | $18 → $22 | Maintains | Buy |
07/02/2020 | 1141.38% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
11/22/2019 | 451.72% | Maxim Group | → $8 | Upgrades | Hold → Buy |
日期 | 上行/下行空間 | 分析師公司 | 價格目標變更 | 評級變化 | 之前/現今評級 |
---|---|---|---|---|---|
08/24/2023 | 175.86% | HC韋恩賴特公司 | → $4 | 重申 | 買入 → 買入 |
08/14/2023 | 175.86% | HC韋恩賴特公司 | $5 → $4 | 維持 | 買入 |
07/14/2023 | 244.83% | HC韋恩賴特公司 | 變成$5 | 重申 | 買入 → 買入 |
05/12/2023 | 244.83% | HC韋恩賴特公司 | 變成$5 | 重申 | 買入 → 買入 |
05/08/2023 | 244.83% | HC韋恩賴特公司 | 變成$5 | 重申 | 買入 |
03/30/2023 | 244.83% | HC韋恩賴特公司 | 變成$5 | 重申 | 買入 |
03/23/2023 | 244.83% | HC韋恩賴特公司 | 變成$5 | 重申 | 買入 |
02/10/2023 | 244.83% | HC韋恩賴特公司 | 變成$5 | 重申 | 買入 |
12/15/2022 | 244.83% | HC韋恩賴特公司 | $8 → $5 | 維持 | 買入 |
08/08/2022 | 451.72% | HC韋恩賴特公司 | $4變成$8 | 維持 | 買入 |
05/16/2022 | 175.86% | HC韋恩賴特公司 | $6 → $4 | 維持 | 買入 |
02/11/2022 | 313.79% | HC韋恩賴特公司 | $8 → $6 | 維持 | 買入 |
08/13/2021 | 658.62% | HC韋恩賴特公司 | $13 → $11 | 維持 | 買入 |
04/22/2021 | 796.55% | HC韋恩賴特公司 | $14 → $13 | 維持 | 買入 |
02/12/2021 | 1555.17% | Roth資本 | → 24美元 | 開始覆蓋 | 買入 |
01/14/2021 | 865.52% | HC韋恩賴特公司 | $18變爲$14 | 維持 | 買入 |
01/11/2021 | 1141.38% | HC韋恩賴特公司 | $12 → $18 | 維持 | 買入 |
11/30/2020 | 1279.31% | HC韋恩賴特公司 | $22 → $20 | 維持 | 買入 |
07/20/2020 | 1417.24% | HC韋恩賴特公司 | $18 → $22 | 維持 | 買入 |
07/02/2020 | 1141.38% | HC韋恩賴特公司 | → 18美元 | 開始覆蓋 | 買入 |
11/22/2019 | 451.72% | Maxim Group | → $8 | 升級 | 持有 → 買入 |
What is the target price for Applied DNA Sciences (APDN)?
applied dna sciences的目標價是多少(APDN)?
The latest price target for Applied DNA Sciences (NASDAQ: APDN) was reported by HC Wainwright & Co. on August 24, 2023. The analyst firm set a price target for $4.00 expecting APDN to rise to within 12 months (a possible 175.86% upside). 9 analyst firms have reported ratings in the last year.
applied dna sciences的最新價格目標是由HC Wainwright&Co.於2023年8月24日報告的。分析師公司設定了4.00美元的價格目標,預計APDN在12個月內上漲(可能上漲175.86%)。在過去的一年中,有9家分析師公司報告了評級。
What is the most recent analyst rating for Applied DNA Sciences (APDN)?
applied dna sciences (APDN)的最新分析師評級是什麼?
The latest analyst rating for Applied DNA Sciences (NASDAQ: APDN) was provided by HC Wainwright & Co., and Applied DNA Sciences reiterated their buy rating.
applied dna sciences (納斯達克:APDN)的最新分析師評級是由HC Wainwright&Co.提供的,applied dna sciences重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Applied DNA Sciences (APDN)?
applied dna sciences (APDN)的下一個分析師評級將在何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Applied DNA Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Applied DNA Sciences was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
分析師通過進行廣泛的研究來得出股票評級,其中包括查閱公開的基本報表,與applied dna sciences的高管和客戶交談,以及收聽業績會議電話。大多數分析師每三個月做一次這樣的評級,所以每年每家公司每家公司應該會獲得4個評級。applied dna sciences的最後一個評級是在2023年8月24日提交的,因此您應該預計下一個評級將在2024年8月24日左右公佈。
Is the Analyst Rating Applied DNA Sciences (APDN) correct?
applied dna sciences (APDN)的分析師評級正確嗎?
While ratings are subjective and will change, the latest Applied DNA Sciences (APDN) rating was a reiterated with a price target of $0.00 to $4.00. The current price Applied DNA Sciences (APDN) is trading at is $1.45, which is within the analyst's predicted range.
儘管評級是主觀的並會發生變化,但最新的applied dna sciences (APDN)評級是重申,價格區間爲0.00至4.00美元。目前的applied dna sciences (APDN)價格爲1.45美元,這在分析師預測的區間內。
譯文內容由第三人軟體翻譯。